These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 797180)

  • 21. Isolation of Cryptococcus neoformans from pigeon manure on two media inducing pigment formation.
    Schønheyder H; Stenderup A
    Sabouraudia; 1982 Sep; 20(3):193-7. PubMed ID: 6753189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular iron chelation in Cryptococcus neoformans.
    Jacobson ES; Petro MJ
    J Med Vet Mycol; 1987 Dec; 25(6):415-8. PubMed ID: 3325632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of Cryptococcus neoformans.
    Staib F; Grave B; Altmann L; Mishra SK; Abel T; Blisse A
    Mycopathologia; 1978 Dec; 65(1-3):73-6. PubMed ID: 370607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cryptococcoma and amphotericin B. Therapy of cryptococcosis - animal experiments. 2nd Communication: Patho-histological results (author's transl)].
    Grosse G; Staib F; Radlmeier E; Preuss W
    Zentralbl Bakteriol Orig A; 1975; 230(4):518-33. PubMed ID: 1096511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The isolation and characterization of virulence factors of Cryptococcus spp. from saprophytic sources in the city of Ribeirão Preto, São Paulo, Brazil.
    Pedroso RS; Ferreira JC; Candido RC
    Microbiol Res; 2009; 164(2):221-7. PubMed ID: 17428645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrogen source-dependent capsule induction in human-pathogenic cryptococcus species.
    Frazzitta AE; Vora H; Price MS; Tenor JL; Betancourt-Quiroz M; Toffaletti DL; Cheng N; Perfect JR
    Eukaryot Cell; 2013 Nov; 12(11):1439-50. PubMed ID: 23975889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pigment production by Cryptococcus neoformans from para- and ortho-Diphenols: effect of the nitrogen source.
    Chaskes S; Tyndall RL
    J Clin Microbiol; 1975 Jun; 1(6):509-14. PubMed ID: 1100669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caffeic acid-containing medium for identification of Cryptococcus neoformans.
    Hopfer RL; Blank F
    J Clin Microbiol; 1976 Aug; 2(2):115-20. PubMed ID: 786998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creatinine metabolism in Cryptococcus neoformans and Cryptococcus bacillisporus.
    Polacheck I; Kwon-Chung KJ
    J Bacteriol; 1980 Apr; 142(1):15-20. PubMed ID: 6989801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A strain of urease negative Cryptococcus neoformans isolated from the environment in China.
    Li A; Guo N; Wu S
    Chin Med Sci J; 1993 Mar; 8(1):52-4. PubMed ID: 8274725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Capsule formation in saprophytic yeasts].
    Golubev VI; Manukian AR
    Mikrobiologiia; 1979; 48(2):314-8. PubMed ID: 375043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanogenesis in Cryptococcus neoformans.
    Polacheck I; Kwon-Chung KJ
    J Gen Microbiol; 1988 Apr; 134(4):1037-41. PubMed ID: 3141580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterologous expression of a gene of Magnaporthe oryzae chrysovirus 1 strain A disrupts growth of the human pathogenic fungus Cryptococcus neoformans.
    Urayama S; Fukuhara T; Moriyama H; Toh-E A; Kawamoto S
    Microbiol Immunol; 2014 May; 58(5):294-302. PubMed ID: 24641700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.
    Small JM; Mitchell TG
    Infect Immun; 1986 Dec; 54(3):742-50. PubMed ID: 3536747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid in vitro capsule production by cryptococci.
    Anna EJ
    Am J Med Technol; 1979 Jun; 45(6):585-8. PubMed ID: 382848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of some Cryptococcus neoformans hypha-forming strains to standard strains and to other species of yeasts as determined by deoxyribonucleic acid base ratios and homologies.
    Erke KH; Schneidau JD
    Infect Immun; 1973 Jun; 7(6):941-8. PubMed ID: 4577418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of arginine auxotrophs of Cryptococcus neoformans.
    Rhodes JC; Howard DH
    Infect Immun; 1980 Mar; 27(3):910-4. PubMed ID: 6991434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic medium containing inositol, urea, and caffeic acid for selective growth of Cryptococcus neoformans.
    Healy ME; Dillavou CL; Taylor GE
    J Clin Microbiol; 1977 Oct; 6(4):387-91. PubMed ID: 334795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical variation of Cryptococcus neoformans.
    Schmeding KA; Jong SC; Hugh R
    Mycopathologia; 1984 Feb; 84(2-3):121-31. PubMed ID: 6371540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudohyphal forms of Cryptococcus neoformans: decreased survival in vivo.
    Neilson JB; Fromtling RA; Bulmer GS
    Mycopathologia; 1981 Jan; 73(1):57-9. PubMed ID: 7012632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.